Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

OTHER(2)

MIXED(1)

retrospective observational study with no intervention

1 trial

wroclaw-medical-university

Metformin

1 trial

phase_4

wroclaw-medical-university

completing surveys

1 trial

wroclaw-medical-university

3 unique interventions2 categories

Analytics

Trial Phases

Phase 41

Trial Status

Completed3

Role Distribution

Principal Investigator2

Other Roles1

PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT05200767Completed

Physical Activity and the Course of COVID-19

COVID-19

StudychairStart date: 2022-01-03

NCT03398356Phase 4Completed

Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.

Impaired Fasting Glucose (IFG)Impaired Glucose Tolerance (IGT)PreDiabetes

PrincipalinvestigatorStart date: 2017-10-20

NCT03426566Completed

Abnormal Plantar Pressure in Patients With Diabetes

Diabetes Complications

PrincipalinvestigatorStart date: 2012-09-01

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

COVID-191 Diabetes Complications1 Impaired Fasting Glucose (IFG)1 Glucose Intolerance1 Prediabetic State1

Affiliations

Wroclaw Medical University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zhaoping Li, MD, PhD

University of California, Los Angeles

17 trials

Shared therapeutic areas:

Glucose IntolerancePrediabetic State

Similarity Score12%

David Crowley, MD

KGK Science Inc.

54 trials

Shared therapeutic areas:

Prediabetic StateCOVID-19

Similarity Score12%

Britt Burton-Freeman, ph.D

Illinois Institute of Technology

23 trials

Shared therapeutic areas:

Glucose IntolerancePrediabetic State

Similarity Score12%

Ali MA Ismail, lecturer

Cairo University

27 trials

Shared therapeutic areas:

Prediabetic State

Similarity Score6%

Xiaolong Qi, MD

LanZhou University

8 trials

Shared therapeutic areas:

COVID-19

Similarity Score6%

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

COVID-19

Similarity Score6%

Sonia Caprio, MD

Yale University

9 trials

Shared therapeutic areas:

Glucose Intolerance

Similarity Score6%

Toshimitsu Tokimoto

Astrazeneca KK

16 trials

Shared therapeutic areas:

COVID-19

Similarity Score6%

Mohamed mamdouh Elsayed, MD

Lecturer

11 trials

Shared therapeutic areas:

COVID-19

Similarity Score6%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

23 trials

Shared therapeutic areas:

Glucose Intolerance

Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05200767StudyChair

Physical Activity and the Course of COVID-19

COVID-19

Completed

NCT03398356Phase 4PrincipalInvestigator

Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.

Impaired Fasting Glucose (IFG)Impaired Glucose Tolerance (IGT)PreDiabetes

Completed

NCT03426566PrincipalInvestigator

Abnormal Plantar Pressure in Patients With Diabetes

Diabetes Complications

Completed

All 3 trials loaded